Literature DB >> 12960679

Long-term treatment with nebivolol improves arterial reactivity and reduces ventricular hypertrophy in spontaneously hypertensive rats.

Estela Guerrero1, Felipe Voces, Noelia Ardanaz, María José Montero, Miguel Arévalo, María Angeles Sevilla.   

Abstract

The aim of this study was to assess the effects of long-term nebivolol therapy on high blood pressure, impaired endothelial function in aorta, and damage observed in heart and conductance arteries in spontaneously hypertensive rats (SHR). For this purpose, SHR were treated for 9 weeks with nebivolol (8 mg/kg per day). Untreated SHR and Wistar Kyoto rats were used as hypertensive and normotensive controls, respectively. The left ventricle/body weight ratio was used as an index of cardiac hypertrophy, and to evaluate vascular function, responses induced by potassium chloride, noradrenaline, acetylcholine, and sodium nitroprusside were tested on aortic rings. Aortic morphometry and fibrosis were determined in parallel by a quantitative technique. Systolic blood pressure, measured by the tail-cuff method, was lower in treated SHR than in the untreated group (194 +/- 3 versus 150 +/- 4 mm Hg). The cardiac hypertrophy index was significantly reduced by the treatment. In aortic rings, treatment with nebivolol significantly reduced the maximal response to both KCl and NA in SHR. In vessels precontracted with phenylephrine relaxant, activity due to acetylcholine was higher in normotensive rats than in SHR and the treatment significantly improved this response. The effect of sodium nitroprusside on aortic rings was similar in all groups. Medial thickness and collagen content were significantly reduced in comparison with SHR. In conclusion, the chronic antihypertensive effect of nebivolol in SHR was accompanied by an improvement in vascular structure and function and in the cardiac hypertrophy index.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960679     DOI: 10.1097/00005344-200309000-00005

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

1.  Nebivolol reduces cardiac angiotensin II, associated oxidative stress and fibrosis but not arterial pressure in salt-loaded spontaneously hypertensive rats.

Authors:  Jasmina Varagic; Sarfaraz Ahmad; Jessica L Voncannon; Norihito Moniwa; Stephen W Simington; Bridget K Brosnihan; Patricia E Gallagher; Javad Habibi; James R Sowers; Carlos M Ferrario
Journal:  J Hypertens       Date:  2012-09       Impact factor: 4.844

2.  Effect of nebivolol on beat-to-beat and short-term blood pressure variability in spontaneously hypertensive rats.

Authors:  Facundo Martín Bertera; Julieta Sofía Del Mauro; Ariel Héctor Polizio; Diego Chiappetta; Carlos Alberto Taira; Christian Höcht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-09       Impact factor: 3.000

3.  Protective Effects of Vasodilatory Βeta-Blockers Carvedilol and Nebivolol against Glycerol Model of Rhabdomyolysis-Induced Acute Renal Failure in Rats.

Authors:  Ahmed Atwa; Rehab Hegazy; Nermeen Shaffie; Neamat Yassin; Sanaa Kenawy
Journal:  Open Access Maced J Med Sci       Date:  2016-08-01

4.  Mechanisms of improved aortic stiffness by arotinolol in spontaneously hypertensive rats.

Authors:  Wugang Zhou; Mona Hong; Ke Zhang; Dongrui Chen; Weiqing Han; Weili Shen; Dingliang Zhu; Pingjin Gao
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.